A dose scaling antivenin protocol in treatment of Daboia palaestinae envenomation may reduce morbidity and costs.
<h4>Background</h4>Daboia palaestinae is a leading cause of snakebite envenomation in the eastern Mediterranean, with substantial mortality in the absence of antivenin. Current recommended antivenin dose is 50 ml; however, antivenin is costly, may be difficult to obtain and is associated...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319119 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|